Qube Research & Technologies LTD Cyteir Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$2.71 - $2.84 $10 - $11	4 New	4 $0
Q3 2022 Nov 14, 2022	BUY	$1.99 - $4.05 $1,038 - $2,114	522 Added 4.63%	11,796 $23,000
Q2 2022 Aug 15, 2022	BUY	$1.62 - $4.4 $18,263 - $49,605	11,274 New	11,274 $34,000
Q3 2021 Nov 12, 2021	SELL	$14.57 - $21.86 $235,567 - $353,432	-16,168 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$16.8 - $21.4 $271,622 - $345,995	16,168 New	16,168 $346,000

2.47M

Ticker CYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,413,400
Market Cap $107M
Description
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.